
News|Articles|October 1, 2012
Prepopik (Sodium picosulfate and magnesium oxide and anhydrous citric acid for oral solution)
New molecular entity: FDA approved the combination of sodium picosulfate (a stimulant laxative) and magnesium oxide and anhydrous citric acid (which form magnesium citrate, an osmotic laxative) (Prepopik, Ferring Pharmaceuticals) for cleansing of the colon as a preparation for colonoscopy in adults.
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Spain can offer a healthcare lesson to the United States
2
MHE Week in Review – COVID Shingles Risk, FDA Removes Menopause Therapy Warning and More
3
Keytruda shows survival edge over Tecentriq, Opdivo in older patients with lung cancer
4
Two studies underscore need for more effective, bladder-sparing therapies in high-risk cancer
5

















































